Last reviewed · How we verify
DRibble vaccine
At a glance
| Generic name | DRibble vaccine |
|---|---|
| Also known as | DPV-001 DRibble vaccine |
| Sponsor | Providence Health & Services |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of DRibble Vaccine for Prostate Cancer Patients (PHASE1)
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer (PHASE2)
- The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells (PHASE1)
- Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |